{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:35:37Z","timestamp":1762605337896},"reference-count":56,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":7735,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[1985,8]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> (\u2212)\u2010[<jats:sup>3<\/jats:sup>H]Nicotine was found to bind specifically to membranes of human brains obtained at autopsy. The binding was stereospecific, (\u2212)\u2010nicotine being 40 times more potent than (+)\u2010nicotine in displacing labeled (\u2212)\u2010nicotine. Saturation binding studies revealed the presence of two binding sites with dissociation constant (<jats:italic>K<\/jats:italic><jats:sub>D<\/jats:sub>) values of 8.1 and 86 n<jats:italic>M<\/jats:italic>, and maximum binding capacity (<jats:italic>B<\/jats:italic><jats:sub>max<\/jats:sub>) values of 36 and 90 fmol\/mg protein, respectively. In competition studies, nicotinic agonists were 1,000 times more potent than ganglionic, neuromuscular, and muscarinic blocking drugs in displacing labeled (\u2212)nicotine. IC<jats:sub>50<\/jats:sub> values for cholinergic drugs of (\u2212)[<jats:sup>3<\/jats:sup>H]nicotine binding were as follows: (\u2212)\u2010nicotine, 0.51 n<jats:italic>M<\/jats:italic>; acetylcholine, 12.6 n<jats:italic>M<\/jats:italic>; (+)\u2010nicotine, 19.9 n<jats:italic>M<\/jats:italic>; cytisine, 27.3 n<jats:italic>M<\/jats:italic>; and carbachol, 527 n<jats:italic>M.<\/jats:italic> IC<jats:sub>50<\/jats:sub> values of \u03b1\u2010bungarotoxin, hexamethonium, <jats:italic>d<\/jats:italic>\u2010tubocurarine, and atropine were larger than 50 \u03bc<jats:italic>M.<\/jats:italic> (\u2212)\u2010[<jats:sup>3<\/jats:sup>H]Nicotine binding was highest in the nucleus basalis of Meynert and thalamus and lowest in the cerebral cortex and caudate in the brain regions tested. These results suggest that nicotinic cholinergic receptors are present in human brain and that there are regional differences in the density of these receptors.<\/jats:p>","DOI":"10.1111\/j.1471-4159.1985.tb04029.x","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T17:45:58Z","timestamp":1160070358000},"page":"604-610","source":"Crossref","is-referenced-by-count":79,"title":["Biochemical Characterization of the Nicotinic Cholinergic Receptors in Human Brain: Binding of (\u2014)\u2010[<sup>3<\/sup>H]Nicotine"],"prefix":"10.1111","volume":"45","author":[{"given":"Shun","family":"Shimohama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohatsu","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakuni","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"key":"e_1_2_2_2_1","first-page":"213","article-title":"Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies","volume":"237","author":"Abood L. G.","year":"1979","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90224-6"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7634(81)90018-X"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(83)81134-X"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.11.3536"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902160106"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.1.147"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00577a005"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00681a008"},{"key":"e_1_2_2_11_1","volume-title":"Vergleichende Lokalisationlehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues","author":"Brodmann K.","year":"1909"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90981-7"},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.2.1016"},{"key":"e_1_2_2_14_1","first-page":"538","article-title":"Studies on the cholinergic receptor protein of","volume":"7","author":"Changeaux J. P.","year":"1971","journal-title":"Electrophorus electricus. Mol. Pharmacol."},{"key":"e_1_2_2_15_1","first-page":"392","article-title":"3H\u2010Nicotine binding in rat brain: alteration after chronic actylcholinesterase inhibition","volume":"226","author":"Costa L. G.","year":"1983","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)90148-7"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb08013.x"},{"key":"e_1_2_2_18_1","volume-title":"Structure of the Human Brain: A Photographic Atlas","author":"DeArmond S.J.","year":"1976"},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)91066-1"},{"key":"e_1_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1979.59.1.165"},{"key":"e_1_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1984.tb02817.x"},{"key":"e_1_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-198401000-00001"},{"key":"e_1_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.901670402"},{"key":"e_1_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/09687688009063887"},{"key":"e_1_2_2_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6990490"},{"key":"e_1_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902000202"},{"key":"e_1_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)91053-3"},{"key":"e_1_2_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.901780204"},{"key":"e_1_2_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)90879-X"},{"key":"e_1_2_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_2_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1979.tb05258.x"},{"key":"e_1_2_2_32_1","first-page":"554","article-title":"Characterization of nicotine binding in mouse brain and comparison with the binding of \u03b1\u2010bungarotoxin and quinuclidinyl benzilate","volume":"22","author":"Marks M. J.","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_33_1","first-page":"817","article-title":"Effect of chronic nicotine infusion on tolerance development and nicotinic receptors","volume":"226","author":"Marks M. J.","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_2_34_1","first-page":"6335","article-title":"Studies on nicotinic acetylcholine receptors in mammalian brain","volume":"251","author":"McQuarrie C.","year":"1976","journal-title":"J. Biol. Chem."},{"key":"e_1_2_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902140206"},{"key":"e_1_2_2_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/229554a0"},{"key":"e_1_2_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90335-7"},{"key":"e_1_2_2_38_1","first-page":"217","article-title":"\u03b3\u2010Amino butyric acid receptor binding in mammalian brain: heterogeneity of binding sites","volume":"19","author":"Olsen R. W.","year":"1981","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)90663-2"},{"key":"e_1_2_2_40_1","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1016\/S0021-9258(19)75267-3","article-title":"\u03b1\u2010Bungarotoxin binding and cholinergic receptor function on a rat sympathetic nerve line","volume":"252","author":"Patrick J.","year":"1977","journal-title":"J. Biol. Chem."},{"key":"e_1_2_2_41_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.01-11-01242.1981"},{"key":"e_1_2_2_42_1","first-page":"84","article-title":"Basal forebrain cholinergic systems in Alzheimer's disease and related dementias","volume":"1","author":"Price D. L.","year":"1982","journal-title":"Neurosci. Comment."},{"key":"e_1_2_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(84)90485-3"},{"key":"e_1_2_2_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7433991"},{"key":"e_1_2_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)91117-8"},{"key":"e_1_2_2_46_1","first-page":"283","article-title":"Drug binding properties of an \u03b1\u2010bungarotoxin binding component from rat brain","volume":"13","author":"Schmidt J.","year":"1977","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_47_1","first-page":"56","article-title":"Nicotinic cholinergic receptors labeled by 3H\u2010acetylcholine in rat brain","volume":"22","author":"Schwartz R. D.","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)90381-5"},{"key":"e_1_2_2_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/10799898109038794"},{"key":"e_1_2_2_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/90.3.497"},{"key":"e_1_2_2_51_1","first-page":"171","volume-title":"IBRO Handbook Series: Methods in the Neurosciences, Vol. 2: Brain Microdissection Techniques","author":"Stevens T. J.","year":"1983"},{"key":"e_1_2_2_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.14.4532"},{"key":"e_1_2_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(83)90203-4"},{"key":"e_1_2_2_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902070204"},{"key":"e_1_2_2_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00182a028"},{"key":"e_1_2_2_56_1","first-page":"768","article-title":"Biochemical characterization of the muscarinic cholinergic receptors in Huntington's disease","volume":"143","author":"Wastek G. J.","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90578-X"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.1985.tb04029.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.1985.tb04029.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:07:41Z","timestamp":1697832461000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.1985.tb04029.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["10.1111\/j.1471-4159.1985.tb04029.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.1985.tb04029.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}